Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

265 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
IDH1-mutated Crohn's disease-associated small bowel adenocarcinomas: Distinctive pathological features and association with MGMT methylation and serrated-type dysplasia.
Guerini C, Furlan D, Ferrario G, Grillo F, Libera L, Arpa G, Klersy C, Lenti MV, Riboni R, Solcia E, Fassan M, Mastracci L, Ardizzone S, Moens A, De Hertogh G, Ferrante M, Graham RP, Sessa F, Paulli M, Di Sabatino A, Vanoli A. Guerini C, et al. Among authors: de hertogh g. Histopathology. 2024 Feb;84(3):515-524. doi: 10.1111/his.15095. Epub 2023 Nov 21. Histopathology. 2024. PMID: 37988281
Deep Learning Models Capture Histological Disease Activity in Crohn's Disease and Ulcerative Colitis with High Fidelity.
Rymarczyk D, Schultz W, Borowa A, Friedman JR, Danel T, Branigan P, Chałupczak M, Bracha A, Krawiec T, Warchoł M, Li K, De Hertogh G, Zieliński B, Ghanem LR, Stojmirovic A. Rymarczyk D, et al. Among authors: de hertogh g. J Crohns Colitis. 2024 Apr 23;18(4):604-614. doi: 10.1093/ecco-jcc/jjad171. J Crohns Colitis. 2024. PMID: 37814351 Free PMC article.
Effects of Mirikizumab on Histologic Resolution of Crohn's Disease in a Randomized Controlled Phase 2 Trial.
Magro F, Protic M, De Hertogh G, Chan LS, Pollack P, Jairath V, Carlier H, Hon E, Feagan BG, Harpaz N, Pai R, Reinisch W. Magro F, et al. Among authors: de hertogh g. Clin Gastroenterol Hepatol. 2024 Sep;22(9):1878-1888.e10. doi: 10.1016/j.cgh.2023.11.010. Epub 2023 Nov 20. Clin Gastroenterol Hepatol. 2024. PMID: 37993033 Free article. Clinical Trial.
A Phase 2b, Randomised, Double-blind, Placebo-controlled, Parallel-arm, Multicenter Study Evaluating the Safety and Efficacy of Tesnatilimab in Patients with Moderately to Severely Active Crohn's Disease.
Allez M, Sands BE, Feagan BG, D'Haens G, De Hertogh G, Randall CW, Zou B, Johanns J, O'Brien C, Curran M, Rebuck R, Wang ML, Sabins N, Baker T, Kobayashi T. Allez M, et al. Among authors: de hertogh g. J Crohns Colitis. 2023 Aug 21;17(8):1235-1251. doi: 10.1093/ecco-jcc/jjad047. J Crohns Colitis. 2023. PMID: 36939629 Clinical Trial.
The Tissue Systems Pathology Test Outperforms Pathology Review in Risk Stratifying Patients With Low-Grade Dysplasia.
Khoshiwal AM, Frei NF, Pouw RE; TissueCypher SURF LGD Study Pathologists Consortium; Smolko C, Arora M, Siegel JJ, Duits LC, Critchley-Thorne RJ, Bergman JJGHM. Khoshiwal AM, et al. Gastroenterology. 2023 Nov;165(5):1168-1179.e6. doi: 10.1053/j.gastro.2023.07.029. Epub 2023 Aug 30. Gastroenterology. 2023. PMID: 37657759 Free article. Clinical Trial.
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies.
Rubin DT, Allegretti JR, Panés J, Shipitofsky N, Yarandi SS, Huang KG, Germinaro M, Wilson R, Zhang H, Johanns J, Feagan BG, Hisamatsu T, Lichtenstein GR, Bressler B, Peyrin-Biroulet L, Sands BE, Dignass A; QUASAR Study Group. Rubin DT, et al. Lancet. 2025 Jan 4;405(10472):33-49. doi: 10.1016/S0140-6736(24)01927-5. Epub 2024 Dec 17. Lancet. 2025. PMID: 39706209 Clinical Trial.
Dye-based chromoendoscopy versus i-scan virtual chromoendoscopy in long-standing ulcerative colitis: Multicenter prospective RCT.
Jans A, Sinonquel P, Seerden TCJ, De Bodelier A, de Ridder R, Pierik MJ, Karstensen JG, Sloth S, De Hertogh G, Demedts I, Willekens H, Vermeire S, Bisschops R. Jans A, et al. Among authors: de hertogh g. Endosc Int Open. 2024 Nov 28;12(11):E1386-E1391. doi: 10.1055/a-2443-1080. eCollection 2024 Nov. Endosc Int Open. 2024. PMID: 39610949 Free PMC article.
Development of an automated tool for the estimation of histological remission in ulcerative colitis using single wavelength endoscopy technology.
Sinonquel P, Lenfant M, Eelbode T, Watanabe H, Callaerts B, Bossuyt P, Verstockt B, Sabino JPG, De Hertogh G, Maes F, Vermeire S, Bisschops R. Sinonquel P, et al. Among authors: de hertogh g. J Crohns Colitis. 2024 Nov 27:jjae180. doi: 10.1093/ecco-jcc/jjae180. Online ahead of print. J Crohns Colitis. 2024. PMID: 39602814
Allogeneic abdominal non-vascularized rectus fascia transplantation without immunosuppression equals syngeneic transplantation in a rabbit model at short-term follow-up.
Van De Winkel N, da Cunha MGMCM, Dubois A, Muylle E, Terrie L, Hennion I, De Hertogh G, Fehervary H, Thorrez L, Miserez M, Pirenne J, D'Hoore A, Ceulemans LJ. Van De Winkel N, et al. Among authors: de hertogh g. Transpl Immunol. 2024 Dec;87:102138. doi: 10.1016/j.trim.2024.102138. Epub 2024 Oct 21. Transpl Immunol. 2024. PMID: 39442588
265 results